Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
| REVENUES: | ||||
| Government contract revenue | $ 0 | $ 0 | $ 149,625 | $ 0 |
| Total revenues | 0 | 0 | 149,625 | 0 |
| OPERATING EXPENSES | ||||
| Professional fees | 403,044 | 383,178 | 852,479 | 726,201 |
| Payroll and related expenses | 672,279 | 618,081 | 1,274,844 | 1,248,308 |
| General and administrative | 271,631 | 234,914 | 466,528 | 421,913 |
| Total operating expenses | 1,346,954 | 1,236,173 | 2,593,851 | 2,396,422 |
| OPERATING LOSS | (1,346,954) | (1,236,173) | (2,444,226) | (2,396,422) |
| OTHER EXPENSE | ||||
| Interest and other debt expenses | 55,106 | 61,979 | 110,210 | 250,583 |
| Loss on share for warrant exchanges | 0 | 10,425 | 0 | 130,214 |
| Loss on debt extinguishment | 0 | 0 | 0 | 376,909 |
| Total other expense | 55,106 | 72,404 | 110,210 | 757,706 |
| NET LOSS | (1,402,060) | (1,308,577) | (2,554,436) | (3,154,128) |
| LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS | (8,715) | (4,671) | (14,864) | (8,439) |
| NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. | $ (1,393,345) | $ (1,303,906) | $ (2,539,572) | $ (3,145,689) |
| BASIC AND DILUTED LOSS PER SHARE AVAILABLE TO COMMON STOCKHOLDERS | $ (0.08) | $ (0.14) | $ (0.14) | $ (0.35) |
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED | 17,789,236 | 9,032,157 | 17,771,918 | 8,939,624 |
| X | ||||||||||
- Definition Loss on share for warrant exchanges No definition available.
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Interest and debt related expenses associated with nonoperating financing activities of the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|